• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异时性盆腔高级别黏液炎性纤维母细胞肉瘤与子宫子宫内膜样癌存在共同基因突变:一项罕见病例报告及基因组分析

Heterochronic pelvic high-grade myxoinflammatory fibroblastic sarcoma and uterine endometroid carcinoma harboring common gene mutations: a rare case report with genomic analysis.

作者信息

Higashi Yuriko, Mizuno Mika, Kitazono Ikumi, Akahane Toshiaki, Tasaki Takashi, Noguchi Hirotsugu, Hisaoka Masanori, Kobayashi Hiroaki, Tanimoto Akihide

机构信息

Department of Pathology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.

Department of Obstetrics and Gynecology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.

出版信息

Diagn Pathol. 2025 Jun 3;20(1):71. doi: 10.1186/s13000-025-01669-4.

DOI:10.1186/s13000-025-01669-4
PMID:40462124
Abstract

OBJECTIVE

This report presents a rare case involving an extreme epithelial-to-mesenchymal transition, in which a specific type of sarcoma developed heterochronically as a recurrence of endometrioid carcinoma.

CASE PRESENTATION

A female in her 50's presented with abnormal genital bleeding, and an endometrial biopsy revealed endometrioid carcinoma. Following the diagnosis of stage IA endometrioid carcinoma according to the 2008 classification system of the International Federation of Gynecology and Obstetrics, a robot-assisted simple hysterectomy, bilateral salpingo-oophorectomy, and sentinel lymph node navigation surgery were performed. Six months postoperatively, a tumor mass developed in the pelvis. A transrectal needle biopsy revealed spindle cell proliferation, and pelvic tumor resection was conducted for diagnostic therapy. The patient received no adjuvant chemotherapy or radiotherapy after the second surgery and remained free of tumor recurrence for 8 months. The resected yellowish solid tumor mass, measuring 16 × 12 × 9 cm, exhibited hemorrhage, necrosis, and cystic degeneration and was composed of fascicular proliferation of spindle tumor cells showing nuclear pleomorphism and frequent mitotic figures within a myxoid and inflammatory stroma. No epithelial component or organoid patterns were observed. Immunohistochemically, the tumor cells were positive for factor XIIIa, CD10, and cyclin D1, but negative for keratins (AE1/AE3 and CAM5.2) and other specific markers, supporting a diagnosis of high-grade myxoinflammatory fibroblastic sarcoma (MIFS).

CONCLUSION

Genomic analysis revealed identical mutations in PTEN, PIK3R1, CDKN2 A, and TP53 in both the primary uterine endometrioid carcinoma and heterochronic pelvic MIFS. An integrative approach involving histology, immunohistochemistry, and genomic analysis is critical for elucidating the pathogenesis of rare pelvic and uterine tumors.

摘要

目的

本报告介绍了一例罕见病例,涉及一种极端的上皮-间质转化,其中一种特定类型的肉瘤异时性发生,为子宫内膜样癌的复发。

病例介绍

一名50多岁的女性出现生殖器异常出血,子宫内膜活检显示为子宫内膜样癌。根据2008年国际妇产科联盟的分类系统诊断为IA期子宫内膜样癌后,进行了机器人辅助单纯子宫切除术、双侧输卵管卵巢切除术和前哨淋巴结导航手术。术后6个月,盆腔出现肿瘤肿块。经直肠穿刺活检显示梭形细胞增生,为明确诊断进行了盆腔肿瘤切除术。第二次手术后患者未接受辅助化疗或放疗,8个月内无肿瘤复发。切除的淡黄色实性肿瘤肿块大小为16×12×9cm,有出血、坏死和囊性变,由梭形肿瘤细胞束状增生组成,这些细胞显示核多形性,在黏液样和炎性间质内有频繁的有丝分裂象。未观察到上皮成分或器官样结构。免疫组化显示,肿瘤细胞因子ⅩⅢa、CD10和细胞周期蛋白D1阳性,但角蛋白(AE1/AE3和CAM5.2)及其他特异性标志物阴性,支持高级别黏液炎性纤维母细胞肉瘤(MIFS)的诊断。

结论

基因组分析显示,原发性子宫子宫内膜样癌和异时性盆腔MIFS中PTEN、PIK3R1、CDKN2A和TP53存在相同突变。组织学、免疫组化和基因组分析相结合的方法对于阐明罕见的盆腔和子宫肿瘤的发病机制至关重要。

相似文献

1
Heterochronic pelvic high-grade myxoinflammatory fibroblastic sarcoma and uterine endometroid carcinoma harboring common gene mutations: a rare case report with genomic analysis.异时性盆腔高级别黏液炎性纤维母细胞肉瘤与子宫子宫内膜样癌存在共同基因突变:一项罕见病例报告及基因组分析
Diagn Pathol. 2025 Jun 3;20(1):71. doi: 10.1186/s13000-025-01669-4.
2
Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.辅助阴道近距离放疗治疗 IIB 期分级 2 或 3 期子宫内膜癌的结果和复发模式。
Int J Gynecol Cancer. 2020 Jan;30(1):48-55. doi: 10.1136/ijgc-2019-000675. Epub 2019 Nov 12.
3
Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?子宫和卵巢低级别子宫内膜样癌与未分化癌的关联:一种新型去分化癌?
Int J Gynecol Pathol. 2006 Jan;25(1):52-8. doi: 10.1097/01.pgp.0000183048.22588.18.
4
Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.子宫和卵巢的混合性子宫内膜样腺癌和苗勒管腺肉瘤:强调与癌肉瘤鉴别诊断的临床病理特征。
Am J Surg Pathol. 2021 Mar 1;45(3):374-383. doi: 10.1097/PAS.0000000000001643.
5
Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer - the SENTRY clinical trial.通过前哨淋巴结活检对低中风险子宫内膜癌进行术后管理——SENTRY临床试验
Klin Onkol. 2024;38(2):126-133. doi: 10.48095/ccko2024126.
6
p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.伴有淋巴结转移的子宫内膜低级别子宫内膜样癌中的p53畸变:从免疫组织化学中洞察发病机制的可能线索
Diagn Pathol. 2017 Nov 14;12(1):81. doi: 10.1186/s13000-017-0668-6.
7
[Synchronous primary cancers of the endometrium and ovary: review of 43 cases].[子宫内膜和卵巢同步原发性癌:43例病例回顾]
Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):690-4.
8
Low-grade endometrial endometrioid carcinoma of the p53-abnormal group: case presentation and diagnostic issues.p53异常组的低级别子宫内膜样癌:病例报告及诊断问题
Pathologica. 2024 Oct;116(5):320-323. doi: 10.32074/1591-951X-1044.
9
Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.复发性 KAT6B/A::KANSL1 融合型肿瘤具有侵袭性,其组织形态学上与低级别子宫内膜间质肉瘤重叠。
Am J Surg Pathol. 2022 Sep 1;46(9):1298-1308. doi: 10.1097/PAS.0000000000001915. Epub 2022 May 17.
10
TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.转化生长因子β受体3(TGFBR3)和甲基甘氨酸二甲胺氧化酶5(MGEA5)重排在“混合性”含铁血黄素沉着性纤维脂肪瘤样肿瘤-黏液样炎性成纤维细胞肉瘤中比在经典黏液样炎性成纤维细胞肉瘤中更为常见:一项形态学和荧光原位杂交研究。
Hum Pathol. 2016 Jul;53:14-24. doi: 10.1016/j.humpath.2016.02.005. Epub 2016 Mar 2.

本文引用的文献

1
Treatment strategies for advanced and recurrent endometrial cancer using immune checkpoint inhibitors.使用免疫检查点抑制剂治疗晚期和复发性子宫内膜癌的策略
Int J Clin Oncol. 2025 Feb;30(2):229-240. doi: 10.1007/s10147-024-02689-8. Epub 2025 Jan 15.
2
Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment.子宫内膜癌免疫治疗的进展:对错配修复状态和肿瘤微环境的见解
Cancers (Basel). 2024 Nov 22;16(23):3918. doi: 10.3390/cancers16233918.
3
Uterine Carcinosarcoma (UCS): A Literature Review and Survival Analysis from a Retrospective Cohort Study.
子宫癌肉瘤(UCS):一项回顾性队列研究的文献综述与生存分析
Cancers (Basel). 2024 Nov 21;16(23):3905. doi: 10.3390/cancers16233905.
4
Uterine carcinosarcoma: Unraveling the role of epithelial-to-mesenchymal transition in progression and therapeutic potential.子宫癌肉瘤:解析上皮-间质转化在进展和治疗潜力中的作用。
FASEB J. 2024 Nov 15;38(21):e70132. doi: 10.1096/fj.202401991R.
5
Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment.基于分子病理学的子宫内膜癌治疗定制:现状及对全身和局部治疗的可能影响。
Int J Mol Sci. 2024 Jul 15;25(14):7742. doi: 10.3390/ijms25147742.
6
Recent Advances in the Diagnosis, Pathogenesis, and Management of Myxoinflammatory Fibroblastic Sarcoma.黏液炎症性纤维肉瘤的诊断、发病机制和治疗的最新进展。
Int J Mol Sci. 2024 Jan 17;25(2):1127. doi: 10.3390/ijms25021127.
7
NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype.NF-κB 信号通路在肿瘤上皮-间充质转化过程中的作用。
Cell Commun Signal. 2023 Oct 18;21(1):291. doi: 10.1186/s12964-023-01207-z.
8
The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion.上皮-间充质转化和自噬在胰腺导管腺癌侵袭中的作用。
Cell Death Dis. 2023 Aug 7;14(8):506. doi: 10.1038/s41419-023-06032-3.
9
Fast and reliable Sanger POLE sequencing protocol in FFPE tissues of endometrial cancer.快速可靠的 Sanger POLE 测序协议在子宫内膜癌的 FFPE 组织中。
Pathol Res Pract. 2023 Feb;242:154315. doi: 10.1016/j.prp.2023.154315. Epub 2023 Jan 18.
10
Uterine inflammatory myofibroblastic tumor.子宫炎性肌纤维母细胞瘤。
Pathol Res Pract. 2023 Feb;242:154335. doi: 10.1016/j.prp.2023.154335. Epub 2023 Jan 23.